Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Cannon

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|November 15, 1996
Cardiovascular risk stratification of pulmonary embolismC P Cannon, S Z Goldhaber
Chest|March 1, 1995
The importance of rapidly treating patients with acute myocardial infarctionC P Cannon, S Z Goldhaber
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 10, 2000
Reducing medication errors: potential benefits of bolus thrombolytic agentsC F Richards, C P Cannon
The Journal of Emergency Medicine|July 1, 1995
Waiting for Godot: use of chemical markers in the emergency department evaluation of chest painC P Cannon, R M Walls
Journal of Internal Medicine|June 30, 2007
Myocardial infarction: contemporary management strategiesE V Gelfand, C P Cannon
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 1, 1996
Thrombolysis "door-to-drug" intervalR M Walls, C P Cannon, J Teich
Annals of Internal Medicine|September 12, 1998
The antiplatelet effects of ticlopidine and clopidogrelP J Sharis, C P Cannon, J Loscalzo
International Journal of Clinical Practice|June 20, 2007
Recent trials of lipid loweringK K Ray, C P Cannon, E Braunwald
Circulation|August 1, 1992
An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end pointE Braunwald, C P Cannon, C H McCabe
The American Journal of Cardiology|December 16, 1993
Use of composite endpoints in thrombolysis trials of acute myocardial infarctionE Braunwald, C P Cannon, C H McCabe
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|November 15, 1996
Cardiovascular risk stratification of pulmonary embolismC P Cannon, S Z Goldhaber
Chest|March 1, 1995
The importance of rapidly treating patients with acute myocardial infarctionC P Cannon, S Z Goldhaber
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 10, 2000
Reducing medication errors: potential benefits of bolus thrombolytic agentsC F Richards, C P Cannon
The Journal of Emergency Medicine|July 1, 1995
Waiting for Godot: use of chemical markers in the emergency department evaluation of chest painC P Cannon, R M Walls
Journal of Internal Medicine|June 30, 2007
Myocardial infarction: contemporary management strategiesE V Gelfand, C P Cannon
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 1, 1996
Thrombolysis "door-to-drug" intervalR M Walls, C P Cannon, J Teich
Annals of Internal Medicine|September 12, 1998
The antiplatelet effects of ticlopidine and clopidogrelP J Sharis, C P Cannon, J Loscalzo
International Journal of Clinical Practice|June 20, 2007
Recent trials of lipid loweringK K Ray, C P Cannon, E Braunwald
Circulation|August 1, 1992
An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end pointE Braunwald, C P Cannon, C H McCabe
The American Journal of Cardiology|December 16, 1993
Use of composite endpoints in thrombolysis trials of acute myocardial infarctionE Braunwald, C P Cannon, C H McCabe
Pageof 15